Avsnitt
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss a bacteriophage‑based virus‑like particle vaccine that induces cross‑reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV) by talking about a recent paper from Gu et al in Veterinary Research. Have fun!
This episode was generated using artificial intelligence.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss Phage-antibiotic synergy to combat multidrug-resistant strains of Gram-negative ESKAPE pathogens by examining a recent paper by Morris et al. in Scientific Reports. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the episode's contents.
-
Saknas det avsnitt?
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss the impact of microplastics on bacteriophage activity in aqueous environments by talking about a recent paper from Ochirbat et al. in the Journal of Physical Chemistry. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the episode's contents.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss the bacteriophage potential of SARS-CoV-2 in human gut microbiota by talking about a recent paper by Petrillo et al in F1000. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the episode's contents.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss a method for the targeted discovery of bacteriophages by co-culture, called Phage DisCo, which was recently published in mSystems by Eleanor Rand and her colleagues at Harvard University. Usually, I would say "have fun" here; however, there is also a dark side to this episode: all five federal grants that supported different parts of this work were part of the mass termination of Harvard grants three weeks ago, as confirmed by principal investigator Michael Baym.
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss the in vitro genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii by discussing a recent paper by Sherif et al. in Scientific Reports. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss personalized inhaled bacteriophage therapy for treating multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis by talking about a recent publication by Chan et al in Nature Medicine. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss the effects of Phage–phage competition and biofilms on interactions between two virulent bacteriophages and Pseudomonas aeruginosa, which were recently published by Bürkle et al. in ISME. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will discuss PhageDPO, a machine-learning-based computational framework for identifying phage depolymerases, recently published by Viera et al. in Elsevier's Computers in Biology and Medicine. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will focus on the differences in phage recognition and immunogenicity in humans unraveled in a recent paper by Le et al. in the European Journal of Immunology. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will focus on optimizing phage engineering through an accelerated evolution platform by discussing a recent paper by Favor et al. from Nextbiotics Inc. in Scientific Reports. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will focus on 3D models for mimicking biofilms in diabetic foot ulcers for phage therapy. German researchers from Frankfurt and Jena recently reviewed this topic. The phage lab at the University Hospital Frankfurt was recently featured in Capsid & Tail for having built its own phage laboratory from scratch under very challenging conditions. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Hello and welcome to PhageLine - your line to everything phage.
This week, we will focus on the mechanisms of tailed bacteriophage adsorption. For that, we will discuss a review from Storms and Sauvageau from the Department of Chemical and Materials Engineering at the University of Alberta, which was published in Elsevier's "Virology" in 2015. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Welcome to PhageLine. This week, we will focus on the applications of bacteriophage-derived endolysins for foodborne bacterial pathogens and food safety, a topic recently reviewed by Kahn et al. from Shenzhen University in Frontiers of Microbiology. Have fun!
#medicine #biology #bacteriophages #infection #amr #basicresearch #food #foodsafety
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Welcome to PhageLine. This week, we will focus on CRISPRi-ART, a method for functional genomics of diverse bacteriophages published by Benjamin Adler et al. from the University of California in Nature Microbiology at the end of February. Have fun!
#medicine #biology #bacteriophages #infection #amr #basicresearch #CRISPR #genomics #cas13
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Welcome to PhageLine. This week we will examine the synergistic action of mucoactive drugs and phages against Pseudomonas aeruginosa and Klebsiella pneumoniae. Have fun!
#medicine #biology #bacteriophages #cough #amb #nac #infection #amr
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Welcome to PhageLine. This week we will focus on the molecular basis of foreign DNA recognition by the BREX anti-phage immunity system. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.#medicine #biology #bacteriophages #bacteria #defense #infection #amr
-
Welcome to PhageLine. This week we will focus on a bacteriophage-based method for infection and thrombosis prevention using a phage-immobilized, nitric oxide-releasing surface. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
#medicine #biology #bacteriophages #devices #engineering #thrombosis #infection #amr
-
Welcome to PhageLine. This week we will focus on using specific phage proteins called endolysins instead of whole phages to fight bacteria by discussing the in vitro and in vivo efficacy of an engineered endolysin targeting Gram-negative pathogens. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
-
Welcome to PhageLine. In this week's episode, we will focus on one of the biggest phage papers in 2024: a multicentre, multinational, retrospective observational study of personalized bacteriophage therapy outcomes for 100 consecutive cases headed by Jean-Paul Pirnay and Sarah Djebara.
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
- Visa fler
